ÂÜÀòÂÒÂ×

Mark Lehmkuhle is a seasoned professional in the biomedical engineering field, serving as CEO and CTO of Epitel, Inc. since January 2008, where significant funding of $5.8 million from the NIH was secured for the development of the Epoch wireless transmitter system. Currently, Mark is involved with MedTech Innovator since June 2020, contributing expertise in accelerator programs. Previously, Mark held the position of Research Assistant Professor in the Department of Neurosurgery at the University of Utah from 2008 to December 2017. Mark's academic background includes a PhD in Bioengineering from the University of Utah, a Postdoctoral degree in Biomedical Engineering from the University of Michigan College of Engineering, and a BS in Biomedical Engineering from Case Western Reserve University.